However, we saw no indications of a strong selection, associations to overall CRC risk did not differ by the availability of KRAS/BRAF data in the cohort, and IPW analyses taking selection bias caused by observed characteristics such as tumor stage, tumor site, and age at and year of diagnosis into account did not alter the results. The gene discussed is KRAS; the disease is colorectal carcinoma.